32 Papers
408 Citations
M. Saeed is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 15, co-authored 23 publications.
Chat about Author
Papers
Occlusive and reperfused myocardial infarcts: differentiation with Mn-DPDP--enhanced MR imaging.
M. Saeed,Stefan Wagner,Michael F. Wendland,Nikita Derugin,Walter E. Finkbeiner,Charles B. Higgins +5 more
TL;DR: Mn-DPDP may improve the detection and delineation of acute myocardial Infarcts, demonstrate perfusion of the infarct, and permit discrimination between reperfused and occlusive infarCTs.
97
T1-relaxation kinetics of extracellular, intracellular and intravascular MR contrast agents in normal and acutely reperfused infarcted myocardium using echo-planar MR imaging.
TL;DR: In conclusion, extracellular, intravascular and intracellular MR contrast agents exhibited different T1-relaxation kinetics in both normal and infarcted myocardium.
86
Echo-planar MR imaging of normal and ischemic myocardium with gadodiamide injection.
Michael F. Wendland,M. Saeed,Takayuki Masui,Nikita Derugin,Michael E. Moseley,Charles B. Higgins +5 more
TL;DR: Rapid echo-planar (EP) magnetic resonance (MR) imaging was used to monitor the first pass of a bolus of gadodiamide injection in the hearts of normal rats and rats subjected to left coronary artery occlusion, and myocardial signal intensity recovered slowly following the peak bolus effect.
86
Reperfusion and irreversible myocardial injury: identification with a nonionic MR imaging contrast medium.
TL;DR: Gadodiamide injection provides differential enhancement in reversibly reperfused, irreversibly reperFused, and occlusive infarcts and may be useful as a marker of reperfusion and extent of infarction after thrombolytic therapy.
60
Demarcation of myocardial ischemia: magnetic susceptibility effect of contrast medium in MR imaging.
M. Saeed,Michael F. Wendland,Ernesto Tomei,Scott M. Rocklage,Steven C. Quay,Michael E. Moseley,Christopher L. Wolfe,Charles B. Higgins +7 more
TL;DR: Dysprosium diethylenetriamine-pentaacetic acid-bis (methylamide) (DTPA-BMA), a new nonionic contrast medium for magnetic resonance (MR) imaging, produces signal loss on T2-weighted images because of induced magnetic field gradients, and has the potential to demarcate the myocardial area in jeopardy as a region of high signal intensity.
58